Cybin Inc.
NASDAQCybin Inc. heads into its September 22 earnings event with one of the most concentrated insider buying clusters seen in a clinical-stage biotech this year. Executive Chair Eric So and Chief Growth Officer Paul Glavine have together spent over $8.3 million buying shares in the open market across seven recorded trades since late August — none of it under a pre-arranged 10b5-1 plan. That…
Snapshot as of 19 Sept 2026
Cybin Inc. heads into its September 22 earnings event with one of the most concentrated insider buying clusters seen in a clinical-stage biotech this year. Executive Chair Eric So and Chief Growth Officer Paul Glavine…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HELP — free to start on ORTEX.
Sign up for free →Open HELP on ORTEX